Renal Cancers Terminated Phase 2 Trials for Sorafenib (DB00398)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00496756Sorafenib in Treating Patients With Metastatic or Unresectable Kidney CancerTreatment